That's what the market thought when the biggest in the business released their copycat product. Our SP dropped initially and in time the Nestle A2 products crashed, burned and fizzled out. Surprised after that another player thinks the outcome would be different for them.
Bring it, they have every right to release a copycat product but its likely to also suffer the same fate as Nestle product mainly due to pricing and supply issues. Being a first mover into the A2 category has its advantages.
Karicare A2 FORMULA, page-2
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.87 |
Change
0.020(0.29%) |
Mkt cap ! $4.966B | |||
| Open | High | Low | Value | Volume |
| $6.80 | $6.88 | $6.73 | $9.203M | 1.343M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2379 | $6.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.87 | 8549 | 3 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |